Immunoprevention of colorectal cancer remains a largely untested possibility. The success demonstrated by immunopreventive approaches in mammary carcinoma suggest that this new cancer preventive modality should be investigated for other types of cancer. The design of a successful strategy for colorectal cancer will have to incorporate general concepts that have already been developed for dealing with other tumors, and intestine-specific immunologic strategies.
|Number of pages||14|
|Journal||Gastroenterology Clinics of North America|
|Publication status||Published - Dec 2002|
ASJC Scopus subject areas